ARTICLE | Clinical News
Biogen, Medeva regulatory update
October 31, 1994 8:00 AM UTC
The European Patent Office had revoked the '442 patent, but reversed that decision in July, leaving it to the courts in individual European countries to determine the validity and infringement of the Cambridge, Mass., company's patent. ...